Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. (2009)

First Author: Kenemans P
Attributed to:  Midland Hub for Trials Methodology Research at University of Birmingham funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/S1470-2045(08)70341-3

PubMed Identifier: 19167925

Publication URI: http://europepmc.org/abstract/MED/19167925

Type: Journal Article/Review

Volume: 10

Parent Publication: The Lancet. Oncology

Issue: 2

ISSN: 1470-2045